These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35610401)

  • 21. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
    Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
    Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human bone marrow-derived mesenchymal stem cells display enhanced clonogenicity but impaired differentiation with hypoxic preconditioning.
    Boyette LB; Creasey OA; Guzik L; Lozito T; Tuan RS
    Stem Cells Transl Med; 2014 Feb; 3(2):241-54. PubMed ID: 24436440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypoxia on the proliferation of porcine bone marrow-derived mesenchymal stem cells and adipose-derived mesenchymal stem cells in 2- and 3-dimensional culture.
    Burian E; Probst F; Palla B; Riedel C; Saller MM; Cornelsen M; König F; Schieker M; Otto S
    J Craniomaxillofac Surg; 2017 Mar; 45(3):414-419. PubMed ID: 28110999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomal HMGB1 derived from hypoxia-conditioned bone marrow mesenchymal stem cells increases angiogenesis via the JNK/HIF-1α pathway.
    Gao W; He R; Ren J; Zhang W; Wang K; Zhu L; Liang T
    FEBS Open Bio; 2021 May; 11(5):1364-1373. PubMed ID: 33711197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative and chondrogenic potential of mesenchymal stromal cells from pluripotent and bone marrow cells.
    Sfougataki I; Varela I; Stefanaki K; Karagiannidou A; Roubelakis MG; Kalodimou V; Papathanasiou I; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Kitra V; Tsezou A; Tzetis M; Goussetis E
    Histol Histopathol; 2020 Dec; 35(12):1415-1426. PubMed ID: 32959885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro.
    Connard SS; Linardi RL; Even KM; Berglund AK; Schnabel LV; Ortved KF
    Vet Immunol Immunopathol; 2021 Apr; 234():110203. PubMed ID: 33636546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro.
    Yang YK; Ogando CR; Wang See C; Chang TY; Barabino GA
    Stem Cell Res Ther; 2018 May; 9(1):131. PubMed ID: 29751774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells.
    Kim DS; Ko YJ; Lee MW; Park HJ; Park YJ; Kim DI; Sung KW; Koo HH; Yoo KH
    Cell Stress Chaperones; 2016 Nov; 21(6):1089-1099. PubMed ID: 27565660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
    Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
    Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.
    Chang CP; Chio CC; Cheong CU; Chao CM; Cheng BC; Lin MT
    Clin Sci (Lond); 2013 Feb; 124(3):165-76. PubMed ID: 22876972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
    Xia W; Zhang F; Xie C; Jiang M; Hou M
    Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies.
    Block TJ; Marinkovic M; Tran ON; Gonzalez AO; Marshall A; Dean DD; Chen XD
    Stem Cell Res Ther; 2017 Oct; 8(1):239. PubMed ID: 29078802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mkx mediates tenogenic differentiation but incompletely inhibits the proliferation of hypoxic MSCs.
    Chen G; Fan D; Zhang W; Wang S; Gu J; Gao Y; He L; Li W; Zhang C; Li M; Zhang Y; Liu Z; Hao Q
    Stem Cell Res Ther; 2021 Jul; 12(1):426. PubMed ID: 34321079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease.
    Sohi GK; Farooqui N; Mohan A; Rajagopalan KS; Xing L; Zhu XY; Jordan K; Krier JD; Saadiq IM; Tang H; Hickson LJ; Eirin A; Lerman LO; Herrmann SM
    Stem Cell Res Ther; 2024 Jun; 15(1):162. PubMed ID: 38853239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells.
    Rodriguez LA; Mohammadipoor A; Alvarado L; Kamucheka RM; Asher AM; Cancio LC; Antebi B
    Cells; 2019 May; 8(5):. PubMed ID: 31096722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic preconditioning promotes the immunosuppressive effects of mesenchymal stem cells in mice with colitis.
    Ying J; You Q; Wang Z; Hu Z
    Res Vet Sci; 2022 May; 144():157-163. PubMed ID: 34802776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hypoxia on equine mesenchymal stem cells derived from bone marrow and adipose tissue.
    Ranera B; Remacha AR; Álvarez-Arguedas S; Romero A; Vázquez FJ; Zaragoza P; Martín-Burriel I; Rodellar C
    BMC Vet Res; 2012 Aug; 8():142. PubMed ID: 22913590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.
    Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S
    Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.
    Brown PT; Squire MW; Li WJ
    Cell Tissue Res; 2014 Oct; 358(1):149-64. PubMed ID: 24927918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia Inducible Factor-1α Regulates the Migration of Bone Marrow Mesenchymal Stem Cells via Integrin α 4.
    Choi JH; Lee YB; Jung J; Hwang SG; Oh IH; Kim GJ
    Stem Cells Int; 2016; 2016():7932185. PubMed ID: 26880989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.